|
SIAH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28389999964895E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72807999999636E-05 |
| Normal-vs-Stage2 |
3.864400E-03 |
| Normal-vs-Stage3 |
8.69920000479141E-08 |
| Normal-vs-Stage4 |
4.2825999968521E-08 |
| Stage1-vs-Stage2 |
6.618200E-01 |
| Stage1-vs-Stage3 |
3.215500E-02 |
| Stage1-vs-Stage4 |
1.420230E-02 |
| Stage2-vs-Stage3 |
6.869900E-02 |
| Stage2-vs-Stage4 |
1.947770E-02 |
| Stage3-vs-Stage4 |
4.561600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.2129999994488E-07 |
| Normal-vs-AfricanAmerican |
8.32440000000378E-05 |
| Normal-vs-Asian |
4.807800E-04 |
| Caucasian-vs-AfricanAmerican |
2.402000E-01 |
| Caucasian-vs-Asian |
6.159200E-01 |
| AfricanAmerican-vs-Asian |
1.277230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74416999999538E-05 |
| Normal-vs-Female |
1.83679999987696E-07 |
| Male-vs-Female |
6.330000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.23209999999918E-05 |
| Normal-vs-Age(41-60Yrs) |
3.20030000000582E-06 |
| Normal-vs-Age(61-80Yrs) |
6.86279999495554E-09 |
| Normal-vs-Age(81-100Yrs) |
4.962300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.618800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.642200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.103400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.773600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.784200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.260300E-02 |
| Classical-VS-Follicular |
1.146230E-01 |
| Classical-VS-Other |
4.749200E-01 |
| Classical-VS-Normal |
1.56360999999938E-05 |
| Tall-VS-Follicular |
3.508800E-01 |
| Tall-VS-Other |
1.978840E-01 |
| Tall-VS-Normal |
1.71555999999295E-05 |
| Follicular-VS-Other |
1.421800E-01 |
| Follicular-VS-Normal |
1.61271999999935E-05 |
| Other-VS-Normal |
5.933000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52030000000192E-06 |
| Normal-vs-N1 |
1.54699999999064E-06 |
| N0-vs-N1 |
4.474600E-01 |
|
|
